Published July 4, 2021, 2:52 PM
(FILES) This file photo illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes with the logo of US biotech company Novavax, on November 17, 2020.
JUSTIN TALLIS / AFP
The Food and Drug Administration (FDA) said Sunday, July 4, it is waiting for American biotechnology company Novavax to apply for an emergency use authorization (EUA) for its coronavirus disease (COVID-19) vaccine.
FDA Director-General Rolando Enrique Domingo said that Novavax has already expressed its interest to apply for an EUA in the Philippines.
“Letter of intent palang. Wala pang formal application ([It already sent] a letter of intent. There is no formal application yet),” said Domingo in a text message.